Schaber Christopher J - Insider Stock Trading - OpenInsider

CIK: 1068029 - Address: C/O Soligenix, Inc., 29 Emmons Drive, Suite B-10, Princeton, NJ 08540

16 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	2	1	7	1	2	-1	21	38	45	18
P	%wins				71	57	57	43	83	67	63

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/18/22 18:01	5/18/22	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	9	0.4433	0	20	29	90	D
12/20/21 16:23	12/17/21	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	5	0.7399	0	7	11	70	D
12/14/21 16:05	12/14/21	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	7	0.7269	0	10	19	63	D
11/19/19 16:18	11/19/19	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	10	0.9300	0	11	25	53	D
4/22/19 16:41	4/22/19	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	4	0.7154	0	5	13	42	D
10/18/18 16:51	10/18/18	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	10	1.17	0	9	30	37	D
8/22/18 17:00	8/22/18	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	5	1.42	0	4	14	29	D
12/20/16 10:02	12/16/16	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P.d	50	3.16	0	16	170	25	D	-82	-77	-65	-67	-38	-38	-20	6	2	-3	0	-6
12/23/15 06:02	12/22/15	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P	13	1.29	0	10	13	86	D	-31	23	-50	19	19	37	140	45	-9	-6	-19	-32	-44	-80
12/24/14 10:06	12/22/14	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P.d	10	1.21	0	8	12	76	D	76	-43	-52	-49	-46	-33	-27	-24	-1	-4	6	63	135	12
6/26/13 16:18	6/25/13	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB,CEO,P	P.d	10	1.05	0	10	19	60	D	-76	220	66	-27	-30	-45	-40	-36	6	0	46	120	83	119
4/11/12 19:12	4/10/12	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CB CEO,P	P	5	0.5098	0	10	25	50	D	-91	-88	-40	-20	-23	-9	-4	7	0	0	-25	-23	29	196
9/30/09 15:43	9/28/09	SNGX	Soligenix, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	NJ	DO	CEO	P.d	20	0.2530	0	79	20	472	D	-27	170	145	50	29	42	0	8	4	15	-26	-7	0	-30
8/29/07 12:51	8/28/07	DORB	Dor Biopharma Inc	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	FL	DO	CEO	P	29	0.2906	0	100	34	393	D
2/13/07 07:56	2/9/07	DORB	Dor Biopharma Inc	DE	Health	Drug	Pharmaceutical Preparations	Schaber Christopher J	FL	DO	CEO	P.d	100	0.4700	0	213	266	293	D
3/17/05 13:16	3/17/05	DSCO	Discovery Laboratories Inc /de/	DE	Health	BioPrd	Biological Products, (No Diag	Schaber Christopher	PA	O	Exec. VP	P	79	5.23	0	15	7	223	D	216	-56	-38	-42	-15	-13	1	0	8	12	12	29	22	53

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact